[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bisoprolol Fumarate Market Growth 2023-2029

March 2023 | 97 pages | ID: G85BD93F4BCCEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Bisoprolol Fumarate is the fumarate salt of a synthetic phenoxy-2-propanol-derived cardioselective beta-1 adrenergic receptor antagonist with antihypertensive and potential cardioprotective activities. Devoid of intrinsic sympathomimetic activity, bisoprolol selectively and competitively binds to and blocks beta-1 adrenergic receptors in the heart, decreasing cardiac contractility and rate, reducing cardiac output, and lowering blood pressure. In addition, this agent may exhibit antihypertensive activity through the inhibition of renin secretion by juxtaglomerular epithelioid (JGE) cells in the kidney, thus inhibiting activation of the renin-angiotensin system (RAS). Bisoprolol has been shown to be cardioprotective in animal models.

LPI (LP Information)' newest research report, the “Bisoprolol Fumarate Industry Forecast” looks at past sales and reviews total world Bisoprolol Fumarate sales in 2022, providing a comprehensive analysis by region and market sector of projected Bisoprolol Fumarate sales for 2023 through 2029. With Bisoprolol Fumarate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bisoprolol Fumarate industry.

This Insight Report provides a comprehensive analysis of the global Bisoprolol Fumarate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bisoprolol Fumarate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bisoprolol Fumarate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bisoprolol Fumarate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bisoprolol Fumarate.

The global Bisoprolol Fumarate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Bisoprolol Fumarate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Bisoprolol Fumarate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Bisoprolol Fumarate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Bisoprolol Fumarate players cover Merck & Co Inc, Intaspharma, Taj Pharma, Jincheng Taier, Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd., Chengdu Easton Biopharmaceuticals Co., Ltd., The Yueyang Xinhua Pharmaceutical Co., Ltd. and Wellso Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Bisoprolol Fumarate market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Bisoprolol Fumarate Tablets
  • Bisoprolol Fumarate Capsules
Segmentation by application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck & Co Inc
  • Intaspharma
  • Taj Pharma
  • Jincheng Taier
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Jiangsu Simcere Pharmaceutical Co., Ltd.
  • Chengdu Easton Biopharmaceuticals Co., Ltd.
  • The Yueyang Xinhua Pharmaceutical Co., Ltd.
  • Wellso Pharmaceutical
Key Questions Addressed in this Report

What is the 10-year outlook for the global Bisoprolol Fumarate market?

What factors are driving Bisoprolol Fumarate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bisoprolol Fumarate market opportunities vary by end market size?

How does Bisoprolol Fumarate break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bisoprolol Fumarate Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Bisoprolol Fumarate by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Bisoprolol Fumarate by Country/Region, 2018, 2022 & 2029
2.2 Bisoprolol Fumarate Segment by Type
  2.2.1 Bisoprolol Fumarate Tablets
  2.2.2 Bisoprolol Fumarate Capsules
2.3 Bisoprolol Fumarate Sales by Type
  2.3.1 Global Bisoprolol Fumarate Sales Market Share by Type (2018-2023)
  2.3.2 Global Bisoprolol Fumarate Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Bisoprolol Fumarate Sale Price by Type (2018-2023)
2.4 Bisoprolol Fumarate Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Online Pharmacy
  2.4.4 Others
2.5 Bisoprolol Fumarate Sales by Application
  2.5.1 Global Bisoprolol Fumarate Sale Market Share by Application (2018-2023)
  2.5.2 Global Bisoprolol Fumarate Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Bisoprolol Fumarate Sale Price by Application (2018-2023)

3 GLOBAL BISOPROLOL FUMARATE BY COMPANY

3.1 Global Bisoprolol Fumarate Breakdown Data by Company
  3.1.1 Global Bisoprolol Fumarate Annual Sales by Company (2018-2023)
  3.1.2 Global Bisoprolol Fumarate Sales Market Share by Company (2018-2023)
3.2 Global Bisoprolol Fumarate Annual Revenue by Company (2018-2023)
  3.2.1 Global Bisoprolol Fumarate Revenue by Company (2018-2023)
  3.2.2 Global Bisoprolol Fumarate Revenue Market Share by Company (2018-2023)
3.3 Global Bisoprolol Fumarate Sale Price by Company
3.4 Key Manufacturers Bisoprolol Fumarate Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bisoprolol Fumarate Product Location Distribution
  3.4.2 Players Bisoprolol Fumarate Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BISOPROLOL FUMARATE BY GEOGRAPHIC REGION

4.1 World Historic Bisoprolol Fumarate Market Size by Geographic Region (2018-2023)
  4.1.1 Global Bisoprolol Fumarate Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Bisoprolol Fumarate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bisoprolol Fumarate Market Size by Country/Region (2018-2023)
  4.2.1 Global Bisoprolol Fumarate Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Bisoprolol Fumarate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bisoprolol Fumarate Sales Growth
4.4 APAC Bisoprolol Fumarate Sales Growth
4.5 Europe Bisoprolol Fumarate Sales Growth
4.6 Middle East & Africa Bisoprolol Fumarate Sales Growth

5 AMERICAS

5.1 Americas Bisoprolol Fumarate Sales by Country
  5.1.1 Americas Bisoprolol Fumarate Sales by Country (2018-2023)
  5.1.2 Americas Bisoprolol Fumarate Revenue by Country (2018-2023)
5.2 Americas Bisoprolol Fumarate Sales by Type
5.3 Americas Bisoprolol Fumarate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bisoprolol Fumarate Sales by Region
  6.1.1 APAC Bisoprolol Fumarate Sales by Region (2018-2023)
  6.1.2 APAC Bisoprolol Fumarate Revenue by Region (2018-2023)
6.2 APAC Bisoprolol Fumarate Sales by Type
6.3 APAC Bisoprolol Fumarate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bisoprolol Fumarate by Country
  7.1.1 Europe Bisoprolol Fumarate Sales by Country (2018-2023)
  7.1.2 Europe Bisoprolol Fumarate Revenue by Country (2018-2023)
7.2 Europe Bisoprolol Fumarate Sales by Type
7.3 Europe Bisoprolol Fumarate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bisoprolol Fumarate by Country
  8.1.1 Middle East & Africa Bisoprolol Fumarate Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Bisoprolol Fumarate Revenue by Country (2018-2023)
8.2 Middle East & Africa Bisoprolol Fumarate Sales by Type
8.3 Middle East & Africa Bisoprolol Fumarate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bisoprolol Fumarate
10.3 Manufacturing Process Analysis of Bisoprolol Fumarate
10.4 Industry Chain Structure of Bisoprolol Fumarate

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bisoprolol Fumarate Distributors
11.3 Bisoprolol Fumarate Customer

12 WORLD FORECAST REVIEW FOR BISOPROLOL FUMARATE BY GEOGRAPHIC REGION

12.1 Global Bisoprolol Fumarate Market Size Forecast by Region
  12.1.1 Global Bisoprolol Fumarate Forecast by Region (2024-2029)
  12.1.2 Global Bisoprolol Fumarate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bisoprolol Fumarate Forecast by Type
12.7 Global Bisoprolol Fumarate Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck & Co Inc
  13.1.1 Merck & Co Inc Company Information
  13.1.2 Merck & Co Inc Bisoprolol Fumarate Product Portfolios and Specifications
  13.1.3 Merck & Co Inc Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Merck & Co Inc Main Business Overview
  13.1.5 Merck & Co Inc Latest Developments
13.2 Intaspharma
  13.2.1 Intaspharma Company Information
  13.2.2 Intaspharma Bisoprolol Fumarate Product Portfolios and Specifications
  13.2.3 Intaspharma Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Intaspharma Main Business Overview
  13.2.5 Intaspharma Latest Developments
13.3 Taj Pharma
  13.3.1 Taj Pharma Company Information
  13.3.2 Taj Pharma Bisoprolol Fumarate Product Portfolios and Specifications
  13.3.3 Taj Pharma Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Taj Pharma Main Business Overview
  13.3.5 Taj Pharma Latest Developments
13.4 Jincheng Taier
  13.4.1 Jincheng Taier Company Information
  13.4.2 Jincheng Taier Bisoprolol Fumarate Product Portfolios and Specifications
  13.4.3 Jincheng Taier Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Jincheng Taier Main Business Overview
  13.4.5 Jincheng Taier Latest Developments
13.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
  13.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
  13.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
  13.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
  13.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.6 Jiangsu Simcere Pharmaceutical Co., Ltd.
  13.6.1 Jiangsu Simcere Pharmaceutical Co., Ltd. Company Information
  13.6.2 Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
  13.6.3 Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Jiangsu Simcere Pharmaceutical Co., Ltd. Main Business Overview
  13.6.5 Jiangsu Simcere Pharmaceutical Co., Ltd. Latest Developments
13.7 Chengdu Easton Biopharmaceuticals Co., Ltd.
  13.7.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Company Information
  13.7.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
  13.7.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Main Business Overview
  13.7.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Latest Developments
13.8 The Yueyang Xinhua Pharmaceutical Co., Ltd.
  13.8.1 The Yueyang Xinhua Pharmaceutical Co., Ltd. Company Information
  13.8.2 The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
  13.8.3 The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 The Yueyang Xinhua Pharmaceutical Co., Ltd. Main Business Overview
  13.8.5 The Yueyang Xinhua Pharmaceutical Co., Ltd. Latest Developments
13.9 Wellso Pharmaceutical
  13.9.1 Wellso Pharmaceutical Company Information
  13.9.2 Wellso Pharmaceutical Bisoprolol Fumarate Product Portfolios and Specifications
  13.9.3 Wellso Pharmaceutical Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Wellso Pharmaceutical Main Business Overview
  13.9.5 Wellso Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Bisoprolol Fumarate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bisoprolol Fumarate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Bisoprolol Fumarate Tablets
Table 4. Major Players of Bisoprolol Fumarate Capsules
Table 5. Global Bisoprolol Fumarate Sales by Type (2018-2023) & (K Units)
Table 6. Global Bisoprolol Fumarate Sales Market Share by Type (2018-2023)
Table 7. Global Bisoprolol Fumarate Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bisoprolol Fumarate Revenue Market Share by Type (2018-2023)
Table 9. Global Bisoprolol Fumarate Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Bisoprolol Fumarate Sales by Application (2018-2023) & (K Units)
Table 11. Global Bisoprolol Fumarate Sales Market Share by Application (2018-2023)
Table 12. Global Bisoprolol Fumarate Revenue by Application (2018-2023)
Table 13. Global Bisoprolol Fumarate Revenue Market Share by Application (2018-2023)
Table 14. Global Bisoprolol Fumarate Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Bisoprolol Fumarate Sales by Company (2018-2023) & (K Units)
Table 16. Global Bisoprolol Fumarate Sales Market Share by Company (2018-2023)
Table 17. Global Bisoprolol Fumarate Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bisoprolol Fumarate Revenue Market Share by Company (2018-2023)
Table 19. Global Bisoprolol Fumarate Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Bisoprolol Fumarate Producing Area Distribution and Sales Area
Table 21. Players Bisoprolol Fumarate Products Offered
Table 22. Bisoprolol Fumarate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bisoprolol Fumarate Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Bisoprolol Fumarate Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bisoprolol Fumarate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bisoprolol Fumarate Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bisoprolol Fumarate Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Bisoprolol Fumarate Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bisoprolol Fumarate Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bisoprolol Fumarate Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bisoprolol Fumarate Sales by Country (2018-2023) & (K Units)
Table 34. Americas Bisoprolol Fumarate Sales Market Share by Country (2018-2023)
Table 35. Americas Bisoprolol Fumarate Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bisoprolol Fumarate Revenue Market Share by Country (2018-2023)
Table 37. Americas Bisoprolol Fumarate Sales by Type (2018-2023) & (K Units)
Table 38. Americas Bisoprolol Fumarate Sales by Application (2018-2023) & (K Units)
Table 39. APAC Bisoprolol Fumarate Sales by Region (2018-2023) & (K Units)
Table 40. APAC Bisoprolol Fumarate Sales Market Share by Region (2018-2023)
Table 41. APAC Bisoprolol Fumarate Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bisoprolol Fumarate Revenue Market Share by Region (2018-2023)
Table 43. APAC Bisoprolol Fumarate Sales by Type (2018-2023) & (K Units)
Table 44. APAC Bisoprolol Fumarate Sales by Application (2018-2023) & (K Units)
Table 45. Europe Bisoprolol Fumarate Sales by Country (2018-2023) & (K Units)
Table 46. Europe Bisoprolol Fumarate Sales Market Share by Country (2018-2023)
Table 47. Europe Bisoprolol Fumarate Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bisoprolol Fumarate Revenue Market Share by Country (2018-2023)
Table 49. Europe Bisoprolol Fumarate Sales by Type (2018-2023) & (K Units)
Table 50. Europe Bisoprolol Fumarate Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Bisoprolol Fumarate Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Bisoprolol Fumarate Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bisoprolol Fumarate Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bisoprolol Fumarate Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bisoprolol Fumarate Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Bisoprolol Fumarate Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Bisoprolol Fumarate
Table 58. Key Market Challenges & Risks of Bisoprolol Fumarate
Table 59. Key Industry Trends of Bisoprolol Fumarate
Table 60. Bisoprolol Fumarate Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bisoprolol Fumarate Distributors List
Table 63. Bisoprolol Fumarate Customer List
Table 64. Global Bisoprolol Fumarate Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Bisoprolol Fumarate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bisoprolol Fumarate Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Bisoprolol Fumarate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bisoprolol Fumarate Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Bisoprolol Fumarate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bisoprolol Fumarate Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Bisoprolol Fumarate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bisoprolol Fumarate Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Bisoprolol Fumarate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bisoprolol Fumarate Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Bisoprolol Fumarate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bisoprolol Fumarate Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Bisoprolol Fumarate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck & Co Inc Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck & Co Inc Bisoprolol Fumarate Product Portfolios and Specifications
Table 80. Merck & Co Inc Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck & Co Inc Main Business
Table 82. Merck & Co Inc Latest Developments
Table 83. Intaspharma Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 84. Intaspharma Bisoprolol Fumarate Product Portfolios and Specifications
Table 85. Intaspharma Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Intaspharma Main Business
Table 87. Intaspharma Latest Developments
Table 88. Taj Pharma Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 89. Taj Pharma Bisoprolol Fumarate Product Portfolios and Specifications
Table 90. Taj Pharma Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Taj Pharma Main Business
Table 92. Taj Pharma Latest Developments
Table 93. Jincheng Taier Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 94. Jincheng Taier Bisoprolol Fumarate Product Portfolios and Specifications
Table 95. Jincheng Taier Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Jincheng Taier Main Business
Table 97. Jincheng Taier Latest Developments
Table 98. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 99. Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
Table 100. Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 102. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 103. Jiangsu Simcere Pharmaceutical Co., Ltd. Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
Table 105. Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Jiangsu Simcere Pharmaceutical Co., Ltd. Main Business
Table 107. Jiangsu Simcere Pharmaceutical Co., Ltd. Latest Developments
Table 108. Chengdu Easton Biopharmaceuticals Co., Ltd. Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 109. Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
Table 110. Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Chengdu Easton Biopharmaceuticals Co., Ltd. Main Business
Table 112. Chengdu Easton Biopharmaceuticals Co., Ltd. Latest Developments
Table 113. The Yueyang Xinhua Pharmaceutical Co., Ltd. Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 114. The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product Portfolios and Specifications
Table 115. The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. The Yueyang Xinhua Pharmaceutical Co., Ltd. Main Business
Table 117. The Yueyang Xinhua Pharmaceutical Co., Ltd. Latest Developments
Table 118. Wellso Pharmaceutical Basic Information, Bisoprolol Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 119. Wellso Pharmaceutical Bisoprolol Fumarate Product Portfolios and Specifications
Table 120. Wellso Pharmaceutical Bisoprolol Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Wellso Pharmaceutical Main Business
Table 122. Wellso Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Bisoprolol Fumarate
Figure 2. Bisoprolol Fumarate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bisoprolol Fumarate Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bisoprolol Fumarate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bisoprolol Fumarate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Bisoprolol Fumarate Tablets
Figure 10. Product Picture of Bisoprolol Fumarate Capsules
Figure 11. Global Bisoprolol Fumarate Sales Market Share by Type in 2022
Figure 12. Global Bisoprolol Fumarate Revenue Market Share by Type (2018-2023)
Figure 13. Bisoprolol Fumarate Consumed in Hospital Pharmacy
Figure 14. Global Bisoprolol Fumarate Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 15. Bisoprolol Fumarate Consumed in Retail Pharmacy
Figure 16. Global Bisoprolol Fumarate Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 17. Bisoprolol Fumarate Consumed in Online Pharmacy
Figure 18. Global Bisoprolol Fumarate Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Bisoprolol Fumarate Consumed in Others
Figure 20. Global Bisoprolol Fumarate Market: Others (2018-2023) & (K Units)
Figure 21. Global Bisoprolol Fumarate Sales Market Share by Application (2022)
Figure 22. Global Bisoprolol Fumarate Revenue Market Share by Application in 2022
Figure 23. Bisoprolol Fumarate Sales Market by Company in 2022 (K Units)
Figure 24. Global Bisoprolol Fumarate Sales Market Share by Company in 2022
Figure 25. Bisoprolol Fumarate Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Bisoprolol Fumarate Revenue Market Share by Company in 2022
Figure 27. Global Bisoprolol Fumarate Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Bisoprolol Fumarate Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Bisoprolol Fumarate Sales 2018-2023 (K Units)
Figure 30. Americas Bisoprolol Fumarate Revenue 2018-2023 ($ Millions)
Figure 31. APAC Bisoprolol Fumarate Sales 2018-2023 (K Units)
Figure 32. APAC Bisoprolol Fumarate Revenue 2018-2023 ($ Millions)
Figure 33. Europe Bisoprolol Fumarate Sales 2018-2023 (K Units)
Figure 34. Europe Bisoprolol Fumarate Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Bisoprolol Fumarate Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Bisoprolol Fumarate Revenue 2018-2023 ($ Millions)
Figure 37. Americas Bisoprolol Fumarate Sales Market Share by Country in 2022
Figure 38. Americas Bisoprolol Fumarate Revenue Market Share by Country in 2022
Figure 39. Americas Bisoprolol Fumarate Sales Market Share by Type (2018-2023)
Figure 40. Americas Bisoprolol Fumarate Sales Market Share by Application (2018-2023)
Figure 41. United States Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Bisoprolol Fumarate Sales Market Share by Region in 2022
Figure 46. APAC Bisoprolol Fumarate Revenue Market Share by Regions in 2022
Figure 47. APAC Bisoprolol Fumarate Sales Market Share by Type (2018-2023)
Figure 48. APAC Bisoprolol Fumarate Sales Market Share by Application (2018-2023)
Figure 49. China Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Bisoprolol Fumarate Sales Market Share by Country in 2022
Figure 57. Europe Bisoprolol Fumarate Revenue Market Share by Country in 2022
Figure 58. Europe Bisoprolol Fumarate Sales Market Share by Type (2018-2023)
Figure 59. Europe Bisoprolol Fumarate Sales Market Share by Application (2018-2023)
Figure 60. Germany Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Bisoprolol Fumarate Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Bisoprolol Fumarate Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Bisoprolol Fumarate Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Bisoprolol Fumarate Sales Market Share by Application (2018-2023)
Figure 69. Egypt Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Bisoprolol Fumarate Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Bisoprolol Fumarate in 2022
Figure 75. Manufacturing Process Analysis of Bisoprolol Fumarate
Figure 76. Industry Chain Structure of Bisoprolol Fumarate
Figure 77. Channels of Distribution
Figure 78. Global Bisoprolol Fumarate Sales Market Forecast by Region (2024-2029)
Figure 79. Global Bisoprolol Fumarate Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Bisoprolol Fumarate Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Bisoprolol Fumarate Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Bisoprolol Fumarate Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Bisoprolol Fumarate Revenue Market Share Forecast by Application (2024-2029)


More Publications